Top

Published in:

01-08-2021 | Intense Pulsed Light | Review Article

Laser and light-based therapies in the management of rosacea: an updated systematic review

Authors: Husein Husein-ElAhmed, Martin Steinhoff

Published in: Lasers in Medical Science | Issue 6/2021

Abstract

Unlike other rosacea therapies which need daily takings or applications over long periods, the edge of lasers and light-based therapies (LLBT) is the limited number of sessions to achieve improvement. The proper selection of the adequate physical device in accordance with the patients’ skin features and rosacea-related signs and symptoms should be considered and the management with physical sources should be updated as new data become available. This article reviews and discusses the current use of lasers and light-based therapies in rosacea with reference to all the available literature.

This systematic review demonstrates the quality of evidence to support any recommendation on LLBT in rosacea is low-to-moderate. Among all the available devices, PDL holds the most robust evidence. Treatments options should be tailored for each specific clinical scenario as it is unlike that single modality results in complete resolution. Platforms that include two or more devices and combined therapies with topical agents are suitable and they warrant further investigations.

Hofmann MA, Lehmann P (2016) Physical modalities for the treatment of rosacea. J Dtsch Dermatol Ges 14(Suppl 6):38–43. https://doi.org/10.1111/ddg.13144CrossRefPubMed

Oxford Center for Evidence-based Medicine Levels of Evidence. Home page. Available from: URL: http://www.cebm.net/index.aspx?0=1025. Accessed February 18, 2020.

Anderson RR, Parrish JA (1981) Microvasculature can be selectively damaged using dye lasers: A basic theory and experimental evidence in human skin. Lasers Surg Med 1(3):263–276PubMedCrossRef

Weinkle AP, Doktor V, Emer J (2015) Update on the management of rosacea. Clin Cosmet Investig Dermatol 8:159–177PubMedPubMedCentral

Cassuto DA, Ancona DM, Emanuelli G (2000) Treatment of facial telangiectasias with a diode-pumped Nd:YAG laser at 532 nm. J Cutan Laser Ther 2(3):141–146PubMedCrossRef

Goldberg DJ, Meine JG (1999) A comparison of four frequencydoubled Nd:YAG (532 nm) laser systems for treatment of facial telangiectases. Dermatol Surg 25(6):463–467PubMedCrossRef

Vasily DB (2002) Use of 532 nm diode-pumped frequency-doubled laser and contact cooling device to enhance clearing of facial telangiectasia. Cosmet Dermatol 15:19–22

Baek JO, Hur H, Ryu HR et al (2017) Treatment of erythematotelangiectatic rosacea with the fractionation of high-fluence, long-pulsed 595-nm pulsed dye laser. J Cosmet Dermatol 16:12–14PubMedCrossRef

Clark SM, Lanigan SW, Marks R (2002) Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci 17(1):26–33PubMedCrossRef

10.

Tunnell JW, Chang DW, Johnston C, Torres JH, Patrick CW, Miller MJ et al (2003) Effects of cryogen spray cooling and high radiant exposures on selective vascular injury during laser irradiation on human skin. Arch Dermatol 139:743–750PubMedCrossRef

11.

Garden BC, Garden JM, Goldberg DJ (2017 Sep) Light-based devices in the treatment of cutaneous vascular lesions: An updated review. J Cosmet Dermatol 16(3):296–302PubMedCrossRef

12.

Uebelhoer NS, Bogle MA, Stewart B, Arndt KA, Dover JS (2007) A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema. Dermatol Surg 33(4):441–448PubMed

13.

Tierney E, Hanke CW (2009) Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser. Lasers Surg Med 41(8):555–562PubMedCrossRef

14.

Carniol PJ, Price J, Olive A (2005) Treatment of telangiectasias with the 532-nm and the 532/940-nm diode laser. Facial Plast Surg 21(2):117–119PubMedCrossRef

15.

Dudelzak J, Hussain M, Goldberg DJ (2009) Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol 8(3):227–229PubMed

16.

Gonzalez E, Gange RW, Momtaz KT (1992) Treatment of telangiectases and other benign vascular lesions with the 577nm pulsed dye laser. J Am Acad Dermatol 27(2 Pt 1):220–226PubMedCrossRef

17.

Patil UA, Dhami LD (2008) Overview of lasers. Indian J Plast Surg 41(Suppl):S101–S113PubMedPubMedCentral

18.

Alora MB, Dover JS, Arndt KA (1999) Lasers for vascular lesions. Dermatol Nurs 11(2):97–102 105-7PubMed

19.

Bernstein EF, Kligman A (2008) Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser. Lasers Surg Med 40(4):233–239PubMedCrossRef

20.

Tan ST, Bialostocki A, Armstrong JR (2004) Pulsed dye laser therapy for rosacea. Br J Plast Surg 57(4):303–310PubMedCrossRef

21.

Iyer S, Fitzpatrick RE (2005) Long-pulsed dye laser treatment for facial telangiectasias and erythema: evaluation of a single purpuric pass versus multiple subpurpuric passes. Dermatol Surg 31(8 Pt 1):898–903PubMedCrossRef

22.

Travelute Ammirati C, Carniol PJ, Hruza GJ (2001) Laser treatment of facial vascular lesions. Facial Plast Surg 17:193–201PubMedCrossRef

23.

Ross EV, Uebelhoer NS, Domankevitz Y (2007) Use of a novel pulse dye laser for rapid single-pass purpura-free treatment of telangiectases. Dermatol Surg 33:1466–1469PubMedCrossRef

24.

Mariethoz E, Polla BS, Gonzalez M, Polla LL (2000) Treatment of facial telangiectasia: a novel application of flashlamp-pumped dye lasers. J Dermatol Treat 11:181–184CrossRef

25.

Rohrer TE, Chatrath V, Iyengar V (2004) Does pulse stacking improve the results of treatment with variable-pulse pulsed-dye lasers? Dermatol Surg 30:163–167PubMed

26.

Alam M, Dover JS, Arndt KA (2003) Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg 29:681–685PubMed

27.

Jasim ZF, Woo WK, Handley JM (2004) Long-pulsed (6-ms) pulsed dye laser treatment of rosacea-associated telangiectasia using subpurpuric clinical threshold. Dermatol Surg 30(1):37–40PubMed

28.

Bernstein EF, Schomacker K, Paranjape A, Jones CJ (2018) Pulsed dye laser treatment of rosacea using a novel 15 mm diameter treatment beam. Lasers Surg Med 50(8):808–812PubMedPubMedCentralCrossRef

29.

Madan V, Ferguson J (2010) Using the ultra-long pulse width pulsed dye laser and elliptical spot to treat resistant nasal telangiectasia. Lasers Med Sci 25(1):151–154PubMedCrossRef

30.

Kim TG, Roh HJ, Cho SB, Lee JH, Lee SJ, Oh SH (2011) Enhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: a randomized, prospective, split-face trial. Br J Dermatol 164(3):573–579PubMed

31.

Kashlan L, Graber EM, Arndt KA (2012) Hair dryer use to optimize pulsed dye laser treatment in rosacea patients. J Clin Aesthet Dermatol 5(6):41–44PubMedPubMedCentral

32.

Suggs AK, Macri A, Richmond H, Munavalli G, Friedman PM (2019) Treatment of Erythematotelangiectatic Rosacea With Pulsed-Dye Laser and Oxymetazoline 1.0% Cream: A Retrospective Study. Lasers Surg Med

33.

Zhang L, Wu ZX, Shen YN et al (2017) The efficacy of hydroxychloroquine combined with 595 nm pulsed dye laser for acne rosacea. J Clin Dermatol 46:413–417

34.

Maxwell EL, Ellis DA, Manis H (2010) Acne rosacea: effectiveness of 532 nm laser on the cosmetic appearance of the skin. J Otolaryngol Head Neck Surg 39(3):292–296PubMed

35.

Huang YC, Li XL, Yang L, Li TJ (2012) Clinical research of topical tacrolimus ointment combined with 585 nm pulsed dye laser in the treatment of rosacea. J Clin Dermatol 41(5):308–309

36.

Seok J, Choi SY, Li K, Kim BJ, Kim MN, Hong CK (2016) Recalcitrant steroid-induced rosacea successfully treated with 0.03% tacrolimus and 595-nm pulsed dye laser. Eur J Dermatol 26(3):312–314PubMedCrossRef

37.

Togsverd-Bo K, Wiegell SR, Wulf HC, Haedersdal M (2009) Short and limited effect of long-pulsed dye laser alone and in combination with photodynamic therapy for inflammatory rosacea. J Eur Acad Dermatol Venereol 23(2):200–201PubMedCrossRef

38.

Kwon HH, Jung JY, Lee WY, Bae Y, Park GH (2019) Combined treatment of recalcitrant papulopustular rosacea involving pulsed dye laser and fractional microneedling radiofrequency with low-dose isotretinoin. J Cosmet Dermatol

39.

Chunharas C, Boen M, Alhaddad M, Wu DC (2019) The Efficacy of Pulsed Dye Laser Pretreated With or Without Local Anesthetic on Patients Presenting With Erythema of Face, Neck, Chest, and Extremities. Lasers Surg Med

40.

Lanigan S (2009) Reduction of pain in the treatment of vascular lesions with a pulsed dye laser and pneumatic skin flattening. Lasers Med Sci 24(4):617–620PubMedCrossRef

41.

Ko HS, Suh YJ, Byun JW, Choi GS, Shin J (2017) Pulsed Dye Laser Treatment Combined with Oral Minocycline Reduces Recurrence Rate of Rosacea. Ann Dermatol 29(5):543–547PubMedPubMedCentralCrossRef

42.

Schilling LM, Halvorson CR, Weiss RA, Weiss MA, Beasley KL (2019) Safety of combination laser or intense pulsed light therapies and doxycycline for the treatment of rosacea. Dermatol Surg 45(11):1401–1405PubMedCrossRef

43.

Lowe NJ, Behr KL, Fitzpatrick R, Goldman M, Ruiz-Esparza J (1991) Flash lamp pumped dye laser for rosacea-associated telangiectasia and erythema. J Dermatol Surg Oncol 17(6):522–525PubMed

44.

Ertaş R, Yaman O, Akkuş MR, Özlü E, Avcı A, Ulaş Y, Ozyurt K, Atasoy M (2019) The rapid effect of pulsed dye laser on demodex density of facial skin. J Cosmet Laser Ther 21(3):123–126PubMedCrossRef

45.

Lonne-Rahm S, Nordlind K, Edström DW, Ros AM, Berg M (2004) Laser treatment of rosacea: a pathoetiological study. Arch Dermatol 140(11):1345–1349PubMedCrossRef

46.

Strand M, Bergqvist G, Griffith S, Bergqvist E (2017) The effect of recurrent pulsed dye laser treatments in rosacea patients. J Cosmet Laser Ther 19(3):160–164PubMedCrossRef

47.

Menezes N, Moreira A, Mota G, Baptista A (2009) Quality of life and rosacea: pulsed dye laser impact. J Cosmet Laser Ther 11(3):139–141PubMedCrossRef

48.

Shim TN, Abdullah A (2013) The Effect of Pulsed Dye Laser on the Dermatology Life Quality Index in Erythematotelangiectatic Rosacea Patients: an assessment. J Clin Aesthet Dermatol 6(4):30–32PubMedPubMedCentral

49.

Tan SR, Tope WD (2004) Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life. J Am Acad Dermatol 51(4):592–599PubMedCrossRef

50.

Bulbul Baskan E, Akin BA (2019) Evaluation of long-term efficacy, safety, and effect on life quality of pulsed dye laser in rosacea patients. J Cosmet Laser Ther 21(4):185–189PubMedCrossRef

51.

Bonsall A, Rajpara S (2016) A review of the quality of life following pulsed dye laser treatment for erythemotelangiectatic rosacea. J Cosmet Laser Ther 18(2):86–90PubMedCrossRef

52.

Cameron H, Ibbotson SH, Ferguson J, Dawe RD, Moseley H (2005) A randomised, blinded, controlled study of the clinical relevance of matching pulse duration to thermal relaxation time when treating facial telangiectasia. Lasers Med Sci 20:117–121PubMedCrossRef

53.

Goldberg DJ, Meine JG (1998) Treatment of facial telangiectases with the diode-pumped frequency-doubled Q-switched Nd:YAG laser. Dermatol Surg 24:828–832PubMedCrossRef

54.

Adrian RM, Tanghetti EA (1998) Long pulse 532-nm laser treatment of facial telangiectasia. Dermatol Surg 24:71–74PubMedCrossRef

55.

Goldberg DJ, Meine JG (1999) A comparison of four frequency-doubled Nd:YAG (532 nm) laser systems for treatment of facial telangiectases. Dermatol Surg 25(6):463–467PubMedCrossRef

56.

Mansouri Y, Goldenberg G (2014) Devices and topical agents for rosacea management. Cutis. 94(1):21–25PubMed

57.

Lee JH, Kim M, Bae JM, Cho BK, Park HJ (2015) Efficacy of the long-pulsed 1064-nm neodymium:yttrium-aluminum-garnet laser (LPND) (rejuvenation mode) in the treatment of papulopustular rosacea (PPR): A pilot study of clinical outcomes and patient satisfaction in 30 cases. J Am Acad Dermatol 73(2):333–336PubMedCrossRef

58.

Black JF, Wade N, Barton JK (2005) Mechanistic comparison of blood undergoing laser photocoagulation at 532 and 1,064 nm. Lasers Surg Med 36:155–165PubMedCrossRef

59.

Lai SW, Goldman MP (2007) Treatment of facial reticular veins with dynamically cooled, variable spot-sized 1064 nm Nd:YAG laser. J Cosmet Dermatol 6:6–8PubMedCrossRef

60.

Miller A (2005) Treatment of erythematotelangiectactic rosacea with a KTP YAG laser. J Drugs Dermatol 4(6):760–762PubMed

61.

Sarradet DM, Hussain M, Goldberg DJ (2003) Millisecond 1,064-nm neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg 29:56–58PubMed

62.

Rose AE, Goldberg DJ (2013) Successful treatment of facial telangiectasias using a micropulse 1,064-nm neodymium-doped yttrium aluminum garnet laser. Dermatol Surg 39:1062–1066PubMedCrossRef

63.

Barton JK, Frangineas G, Pummer H, Black JF (2001) Cooperative phenomena in two-pulse, two-color laser photocoagulation of cutaneous blood vessels. Photochem Photobiol 73:642–650PubMedCrossRef

64.

Goo BL, Kang JS, Cho SB (2015) Treatment of early-stage erythematotelangiectatic rosacea with a Q-switched 595-nm Nd:YAG laser. J Cosmet Laser Ther 17(3):139–142PubMedCrossRef

65.

Karsai S, Roos S, Raulin C (2008) Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation. Dermatol Surg 34:702–708PubMed

66.

Say EM, Gökdemir G (2013) Treatment of rosacea with long-pulsed Nd: YAG laser. Turkderm. 47(1):45–49CrossRef

67.

Say EM, Okan G, Gökdemir G (2015) Treatment outcomes of long-pulsed Nd: YAG laser for two different subtypes of rosacea. J Clin Aesthet Dermatol 8:16–20PubMedPubMedCentral

68.

Hofmann MA, Lehmann P (2016) Physical modalities for the treatment of rosacea. J Dtsch Dermatol Ges 14(Suppl 6):38–43PubMed

69.

70.

Lee JH, Kim M, Bae JM et al (2015) Efficacy of the long-pulsed 1064-nm neodymium:yttrium-aluminum-garnet laser (LPND) (rejuvenation mode) in the treatment of papulopustular rosacea (PPR): A pilot study of clinical outcomes and patient satisfaction in 30 cases. J Am Acad Dermatol 73:333–336PubMedCrossRef

71.

Micali G, Gerber PA, Lacarrubba F, Schafer G (2016) Improving treatment of erythematotelangiectatic rosacea with laser and/or topical therapy through enhanced discrimination of its clinical features. J Clinical Aesthet Dermatol 9(7):30–39

72.

Micali G, Dall'Oglio F, Verzì AE, Luppino I, Bhatt K, Lacarrubba F (2018) Treatment of erythemato-telangiectatic rosacea with brimonidine alone or combined with vascular laser based on preliminary instrumental evaluation of the vascular component. Lasers Med Sci 33(6):1397–1400PubMedCrossRef

73.

Dover JS, Arndt KA (2000) New approaches to the treatment of vascular lesions. Lasers Surg Med 26:158–163PubMedCrossRef

74.

Becher GL, Cameron H, Moseley H (2014) Treatment of superficial vascular lesions with the KTP 532-nm laser: experience with 647 patients. Lasers Med Sci 29(1):267–271PubMedCrossRef

75.

Clark C, Cameron H, Moseley H, Ferguson J, Ibbotson SH (2004) Treatment of superficial cutaneous vascular lesions: Experience with the KTP 532nm laser. Lasers Med Sci 19(1):1–5PubMedCrossRef

76.

Silver BE, Livshots YL (1996) Preliminary experience with the KTP/ 532 nm laser in the treatment of facial telangiectasia. Cosmet Dermatol 9:61–64

77.

Maxwell EL, Ellis DA, Manis H (2010) Acne rosacea: Effectiveness of 532 nm laser on the cosmetic appearance of the skin. J Otolaryngol Head Neck Surg 39:292–296PubMed

78.

Ustuner P, Balevi A, Ozdemir M (2018) The Comparison of the Efficacy and Safety of Q-Switched Potassium Titanyl Phosphate Laser and Long-Pulsed Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Erythematotelangiectatic and Papulopustular Rosacea. Turk J Dermatol 12:90–95CrossRef

79.

Goldman MP (1997) Treatment of benign vascular lesions with the Photoderm VL high-intensity pulsed light source. Adv Dermatol 13:503–521PubMed

80.

Babilas P, Schreml S, Szeimies RM, Landthaler M (2010) Intense pulsed light (IPL): a review. Lasers Surg Med 42(2):93–104PubMedCrossRef

81.

Schroeter CA, Haaf-von Below S, Neumann HA (2005) Effective treatment of rosacea using intense pulsed light systems. Dermatol Surg 31(10):1285–1289PubMedCrossRef

82.

Papageorgiou P, Clayton W, Norwood S, Chopra S, Rustin M (2008) Treatment of rosacea with intense pulsed light: Significant improvement and long-lasting results. Br J Dermatol 159(3):628–632PubMedCrossRef

83.

Bjerring P, Christiansen K, Troilius A (2001) Intense pulsed lightsource for treatment of facial telangiectasias. J Cosmet LaserTher 3(4):169–173

84.

Retamar RA, Chames C, Pellerano G (2004) Treatment of linear and spider telangiectasia with an intense pulsed light source. J Cosmet Dermatol 3(4):187–190PubMedCrossRef

85.

Angermeier MC (1999 Apr) Treatment of facial vascular lesions with intense pulsed light. J Cutan Laser Ther 1(2):95–100PubMedCrossRef

86.

Taub AF (2003) Treatment of rosacea with intense pulsed light. J Drugs Dermatol 2(3):254–259PubMed

87.

Vasily DB (2003) Treatment of rosacea with a long-pulsed flashlamp system. Lasers Surg Med Suppl 15:75

88.

Bashir B, Altaf F, Saleem F, Iftikhar U, Khurshid K, Rani Z, Pal S (2019) Efficacy and safety of intense pulsed light in vascular lesions. J Pak Assoc Dermatol 29(1):4–7

89.

Tsunoda K, Akasaka K, Akasaka T, Amano H (2018) Successful treatment of erythematotelangiectatic rosacea with intense pulsed light: Report of 13 cases. J Dermatol 45(9):1113–1116PubMedCrossRef

90.

Campolmi P, Cannarozzo G, Dragoni F, Conti R, Moretti S (2016) Efficacy of rhodamine light in the treatment of superficial vascular lesions of the face. Med Princ Pract 25:477–482PubMedPubMedCentralCrossRef

91.

Campolmi P, Bonan P, Cannarozzo G, Bruscino N, Troiano M, Prignano F, Lotti T (2011) Intense pulsed light in the treatment of non-aesthetic facial and neck vascular lesions: report of 85 cases. J Eur Acad Dermatol Venreol 25(1):68–73CrossRef

92.

Kassir R, Kolluru A, Kassir M (2011) Intense pulsed light for the treatment of rosacea and telangiectasias. J Cosmet Laser Ther 13(5):216–222PubMedCrossRef

93.

Myers P, Bowler P, Hills S (2005) A retrospective study of the efficacy of intense pulsed light for the treatment of dermatologic disorders presenting to a cosmetic skin clinic. J Cosmet Dermatol 4(4):262–266PubMedCrossRef

94.

Fodor L, Ramon Y, Fodor A, Carmi N, Peled IJ, Ullmann Y (2006) Aside-by-side prospective study of intense pulsed light andNd:YAG laser treatment for vascular lesions. Ann Plast Surg 56(2):164–170PubMedCrossRef

95.

Liu J, Liu J, Ren Y, Li B, Lu S (2014) Comparative efficacy of intense pulsed light for different erythema associated with rosacea. J Cosmet Laser Ther 16(6):324–327PubMedCrossRef

96.

Kawana S, Ochiai H, Tachihara R (2007) Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg 33(4):449–454PubMed

97.

Vissing AE, Dierickx C, Karmisholt KE, Haedersdal M (2018) Topical brimonidine reduces IPL-induced erythema without affecting efficacy: A randomized controlled trial in patients with facial telangiectasias. Lasers Surg Med 50(10):1002–1009PubMedCrossRef

98.

Lim HS, Lee S-C, Won YH, Lee J-B (2014) The Efficacy of Intense Pulsed Light for Treating Erythematotelangiectatic Rosacea Is Related to Severity and Age. Ann Dermatol 26(4):491–495PubMedPubMedCentralCrossRef

99.

Mark KA, Sparacio RM, Voigt A, Marenus K, Sarnoff DS (2003) Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment. Dermatol Surg 29(6):600–604PubMed

100.

Sadick NS (2005) Combination radiofrequency and light energies: electro-optical synergy technology in esthetic medicine. Dermatol Surg 31(9 Pt 2):1211–1217PubMed

101.

Taub AF, Devita EC (2008) Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency. J Clin Aesthet Dermatol 1(1):37–40PubMedPubMedCentral

102.

Wang P, Zhang L, Shi L, Yuan C, Zhang G, Wang X (2019) Latent Demodex infection contributes to intense pulsed light aggravated rosacea: cases serial. J Cosmet Laser Ther 21(3):163–165PubMedCrossRef

103.

Scheepers JH, Quaba AA (1994) Clinical experience in the treatment of the “red nose” using the flashlamp-pumped pulsed dye laser (585 nm). Aesthet Plast Surg 18:57–60CrossRef

104.

Ruiz-Esparza J, Goldman MP, Fitzpatrick RE et al (1993) Flash lamp-pulsed dye laser treatment of telangiectasia. J Dermatol Surg Oncol 19:1000–1003PubMedCrossRef

105.

Nam JT, Kim KH, Joh GY (1994) A study of the therapeutic effect of rosacea by the flashlamp-pumped pulsed dye laser (SPTL-1). Korean J Dermatol 32(4):649–654

106.

Berg M, Edström DW (2004) Flashlamp pulsed dye laser (FPDL) did not cure papulopustular rosacea. Lasers Surg Med 34(3):266–268PubMedCrossRef

107.

Ross M, Watcher MA, Goodman MM (1993) Comparison of the flash lamp pulsed dye laser with the argon tunable dye laser with robotized hand piece for facial telangiectasia. Lasers Surg Med 13:374–378PubMedCrossRef

108.

Broska P, Martinho E, Goodman MM (1994) Comparison of the argon tunable dye laser with the flashlamp pulsed dye laser in treatment of facial telangiectasia. J Dermatol Surg Oncol 20:749–753PubMedCrossRef

109.

Kapicioglu Y, Sarac G, Cenk H (2019) Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser: a case series. Lasers Med Sci 34(1):93–98PubMedCrossRef

110.

Fan L, Yin R, Lan T, Hamblin MR (2018) Photodynamic therapy for rosacea in Chinese patients. Photodiagn Photodyn Ther 24:82–87CrossRef

111.

Sun Y, Chen L, Zhang Y, Gao X, Wu Y, Chen H (2019) Topical photodynamic therapy with 5-aminolevulinic acid in Chinese patients with Rosacea. J Cosmet Laser Ther 21(4):196–200PubMedCrossRef

112.

Friedmann DP, Goldman MP, Fabi SG, Guiha I (2016) Multiple sequential light and laser sources to activate aminolevulinic acid for rosacea. J Cosmet Dermatol. 15(4):407–412PubMedCrossRef

113.

Hongcharu W, Gold M (2015) Expanding the clinical application of fractional radiofrequency treatment: findings on rhytides, hyperpigmentation, rosacea, and acne redness. J Drugs Dermatol 14:1298–1304PubMed

114.

Park S, Kwon H, Yoon J, Min S, Suh D (2016) Clinical and histologic effects of fractional microneedling radiofrequency treatment on rosacea. Dermatol Surg 42:1362–1369PubMedCrossRef

115.

van Zuuren EJ, Fedorowicz Z, Tan J, van der Linden MMD, Arents BWM, Carter B, Charland L (2019) Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol. 181(1):65–79PubMedPubMedCentralCrossRef

Title: Laser and light-based therapies in the management of rosacea: an updated systematic review
Authors: Husein Husein-ElAhmed
Martin Steinhoff
Publication date: 01-08-2021
Publisher: Springer London
Keywords: Intense Pulsed Light
Erythema
Rosacea
Laser
Published in: Lasers in Medical Science / Issue 6/2021
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-020-03200-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Laser and light-based therapies in the management of rosacea: an updated systematic review

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2021

Metagenomic analysis of the dust particles collected from the suction tube and the suction funnel of a dermatological laser smoke evacuator system

The effect of combined curcumin-mediated photodynamic therapy and artificial skin on Staphylococcus aureus–infected wounds in rats

A comprehensive reconstruction strategy for moderate to severe faciocervical scar contractures

Comparative evaluation of improvement in periodontal and glycemic health status of type 2 diabetes mellitus patients after scaling and root planing with or without adjunctive use of diode laser

Stokes polarimetry-based second harmonic generation microscopy for collagen and skeletal muscle fiber characterization

Transurethral laser versus open simple prostatectomy for large volume prostates: a systematic review and meta-analysis of randomized controlled trials